Evidence map›Paper›PMID 38725520›Full record

ArticleChemical science2024

All-photonic kinase inhibitors: light-controlled release-and-report inhibition.

Cassandra L Fleming, Carlos Benitez-Martin, Elin Bernson, Yongjin Xu, Linnea Kristenson, Tord Inghardt, Thomas Lundbäck, Fredrik B Thorén, Morten Grøtli, Joakim Andréasson

Abstract read
In one paragraph

Article in Chemical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cassandra L FlemingDepartment of Chemistry and Chemical Engineering, Physical Chemistry, Chalmers University of Technology SE-41296 Göteborg Sweden a-son@chalmers.se.ORCID https://orcid.org/0000-0002-7730-7305
Carlos Benitez-MartinDepartment of Chemistry and Chemical Engineering, Physical Chemistry, Chalmers University of Technology SE-41296 Göteborg Sweden a-son@chalmers.se.ORCID https://orcid.org/0000-0003-1821-9388
Elin BernsonTIMM Laboratory at Sahlgrenska Centre for Cancer Research, Department of Obstetrics and Gynecology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg SE-41296 Göteborg Sweden.ORCID https://orcid.org/0000-0001-6414-5725
Yongjin XuDepartment of Chemistry and Molecular Biology, University of Gothenburg Box 462 SE-40530 Göteborg Sweden grotli@chem.gu.se.
Linnea KristensonTIMM Laboratory, Sahlgrenska Centre for Cancer Research, Department of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg SE-41296 Göteborg Sweden.
Tord InghardtCardiovascular, Renal and Metabolism, Innovative Medicines and Early Development, AstraZeneca SE-43183 Mölndal Sweden.ORCID https://orcid.org/0000-0002-4804-9474
Thomas LundbäckMechanistic and Structural Biology, Discovery Sciences, R&D, AstraZeneca SE-43183 Mölndal Sweden.ORCID https://orcid.org/0000-0002-8145-7808
Fredrik B ThorénTIMM Laboratory, Sahlgrenska Centre for Cancer Research, Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg SE-41296 Göteborg Sweden.ORCID https://orcid.org/0000-0003-2167-7451
Morten GrøtliDepartment of Chemistry and Molecular Biology, University of Gothenburg Box 462 SE-40530 Göteborg Sweden grotli@chem.gu.se.ORCID https://orcid.org/0000-0003-3621-4222
Joakim AndréassonDepartment of Chemistry and Chemical Engineering, Physical Chemistry, Chalmers University of Technology SE-41296 Göteborg Sweden a-son@chalmers.se.ORCID https://orcid.org/0000-0003-4695-7943

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Light-responsive molecular tools targeting kinases affords one the opportunity to study the underlying cellular function of selected kinases. In efforts to externally control lymphocyte-specific protein tyrosine kinase (LCK) activity, the development of release-and-report LCK inhibitors is described, in which (i) the release of the active kinase inhibitor can be controlled externally with light; and (ii) fluorescence is employed to report both the release and binding of the active kinase inhibitor. This introduces an unprecedented all-photonic method for users to both control and monitor real-time inhibitory activity. A functional cellular assay demonstrated light-mediated LCK inhibition in natural killer cells. The use of coumarin-derived caging groups resulted in rapid cellular uptake and non-specific intracellular localisation, while a BODIPY-derived caging group predominately localised in the cellular membrane. This concept of release-and-report inhibitors has the potential to be extended to other biorelevant targets where both spatiotemporal control in a cellular setting and a reporting mechanism would be beneficial.

Identifiers

PMID38725520
PMCPMC11077529

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.